Idazoxan

DRUG3 trials

Sponsors

Sheba Medical Center, Imperial College London

Conditions

Alzheimer DiseaseHealthy VolunteersMajor Depressive DisorderMolecular Imaging

Early Phase 1

I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

CompletedNCT02323217

Imperial College LondonAlzheimer Disease, Healthy Volunteers, Molecular Imaging

Start: 2015-01-31End: 2016-07-31Updated: 2021-11-15

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD

TerminatedNCT02874820

Imperial College LondonAlzheimer Disease

Start: 2016-07-31End: 2017-07-31Updated: 2020-08-27

Phase 3

The Effectiveness of Idazoxan in Treating TRD

WithdrawnNCT00294944

Sheba Medical CenterMajor Depressive Disorder

Updated: 2008-01-29